- $1.12bn
- $1.75bn
- $418.08m
- 69
- 82
- 48
- 73
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Interest Income | |||||
Interest Expense | |||||
Net Interest Income | 257 | 258 | 272 | 346 | 357 |
Loan Loss Provision | |||||
Net Interest Income After Loan Loss Provision | 259 | 258 | 278 | 328 | 333 |
Non Interest Income | |||||
Non Interest Expense | |||||
Net Income Before Taxes | 127 | 87.3 | 164 | 174 | 161 |
Provision for Income Taxes | |||||
Net Income After Taxes | 92.1 | 64.8 | 118 | 125 | 117 |
Net Income Before Extraordinary Items | |||||
Net Income | 92.1 | 64.8 | 118 | 125 | 117 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 92.1 | 64.8 | 118 | 125 | 117 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.01 | 3.22 | 3.96 | 3.95 | 3.52 |
Dividends per Share |